| Date | Ref. No. | Patent No. | Title |
| 11/10/2009 | E-192-2008/1 | | Optimized Expression of IL-12 Cytokine Family |
| 11/4/2009 | E-273-2009/0 | | Simpler is Better: The Production of Young Cell Cultures from Tumor Infiltrating Lymphocytes (TIL) Yields More Effective Adoptive Cell Transfer (ACT) Immunotherapies |
| 11/4/2009 | E-158-2003/1 | | New Derivative of Dextromethorphan for Use in Neuronal Therapy |
| 10/12/2009 | E-255-2007/0 | | A Target for the Development of Diagnostics and Therapeutics for Abnormal Hematopoiesis |
| 10/10/2009 | E-134-2009/0 | | Engineered Biological Pacemakers |
| 10/7/2009 | E-147-1999/0
E-147-1999/1 | 6,977,245 | Oligodeoxynucleotide and Its Use To Induce an Immune Response |
| 9/21/2009 | E-009-2009/0 | | Treatment of Airway Diseases, Including Asthma and COPD, by Targeting Airway Hyperresponsiveness |
| 9/2/2009 | E-068-2007/0 | | Novel Roles of a DNA Repair Protein, DNA-PKcs, in Obesity, Neurological Function, and Aging |
| 9/2/2009 | E-018-2009/0 | | Biomarkers for Sjögren's Syndrome |
| 7/29/2009 | E-285-2008/0 | | Truncated Methanocarba Adenosine Derivatives as A3 Adenosine Receptor Antagonists |
| 7/29/2009 | E-138-2008/0 | | Non Toxic Peptide Treatment for Dyslipidemic and Vascular Disorders |
| 7/29/2009 | E-040-2004/0 | 7,504,243 | High-yield Methods of Producing Biliverdin |
| 7/3/2009 | E-002-2008/0 | | Modulators of Pregnane X Receptor (PXR) as Therapeutics for Bowel Disorders (BD) |
| 7/2/2009 | E-196-2004/0 | | Bone Morphogenetic Variants, Compositions and Methods of Treatment |
| 7/2/2009 | E-127-1995/0
E-127-1995/1
E-127-1995/2
E-138-1994/0
E-196-2004/0 | 6,884,871
6,924,367
7,049,291
7,148,036
7,220,558
7,563,596 | Novel Osteobiologic Proteins for Treatment of Osteoporosis, Rheumatoid and Neurologic Diseases |
| 7/2/2009 | E-033-2008/0 | | Therapeutic Applications of a p53 Isoform in Regenerative Medicine, Aging, and Cancer |
| 7/2/2009 | E-127-1995/0
E-127-1995/1
E-127-1995/2 | 6,884,871
6,924,367
7,049,291
7,563,596 | Isolation And Use Of Tissue Growth-Inducing FRZB Protein |
| 6/11/2009 | E-164-2007/0 | | Compounds Binding to the N-Terminal Domains of STAT Proteins as Therapeutic Agents |
| 5/15/2009 | E-025-1998/0 | 6,610,684 | Fused Azepinone Cyclin Dependent Kinase Inhibitors |
| 5/5/2009 | E-084-2009/0 | | Genetic Mutations Associated with Stuttering |
| 5/5/2009 | E-338-2005/0 | | Novel Inhibitors of Bone Morphogenetic Proteins |
| 5/4/2009 | E-223-2006/1
E-284-2008/0 | | Small-Molecule TSH Receptor Modulators for Diagnosis and Treatment of Thyroid Disease and Cancer |
| 5/4/2009 | E-003-2000/0 | 7,135,303 | Discovery of a Novel Human Aminopeptidase Which May Regulate Cleavage and Shedding of the Human Type-I Tumor Necrosis Factor Receptor |
| 5/4/2009 | E-193-1997/0 | 6,555,367 | Targeted Recombinant Adenoviral Vectors |
| 3/25/2009 | E-312-2008/0 | | Cell Based Immunotherapy |
| 3/23/2009 | E-219-2007/0
E-219-2007/2 | | Dendrimer Conjugates Targeting Adenosine Receptors, P2Y Receptors and Other Receptors of the GPCR Superfamily, for Use in the Treatment of Various Disorders, Including Neurodegenerative Diseases, Stroke, Epilepsy, Pain and Thrombosis |
| 11/1/2008 | E-250-2007/0 | | Induced Internalization of Surface Receptors |
| 11/1/2008 | E-187-2007/0 | | Indoline Compounds for the Treatment of Spinal Muscular Atrophy (SMA) and Other Diseases |
| 11/1/2008 | E-256-1999/0 | | Methods for Accurately Measuring and Regulating Bound Adrenomedullin |
| 9/1/2008 | E-104-1997/0 | 6,828,309 | Use of Pentosan Polysulfate to Treat Certain Conditions of the Prostate |
| 8/1/2008 | E-140-2008/0 | | Species-Independent A3 Adenosine Receptor Agonists |
| 8/1/2008 | E-227-2006/5 | | Methods of Preventing Tissue Ischemia |
| 7/1/2008 | E-233-2007/0 | | Tendon Stem Cells |
| 7/1/2008 | E-211-2006/0 | | Therapeutic Application of Fatty Acid Amide Hydrolase Inhibitors |
| 7/1/2008 | E-229-2006/0 | | Novel O-GLcNAcase Inhibitor and Fluorogenic Substrate as a Tool for Diagnosing Type 2 Diabetes |
| 7/1/2008 | E-154-2006/0 | | Use of Human Gamma Satellite Insulator Sequences to Prevent Gene Silencing and Allow for Long Term Expression of Integrated Transgenes |
| 7/1/2008 | E-181-1997/0 | 6,479,286 | Methods and Compositions for Making Dendritic Cells from Expanded Populations of Monocytes and for Activating T Cells |
| 7/1/2008 | E-321-2006/0 | | Treatment of Skin Conditions Using DKK1 |
| 5/1/2008 | E-096-2000/0 | 7,531,352 | The Use of an Inducible Plasmid Vector Encoding for Active TGF-beta for the Treatment of Autoimmune Diseases |
| 5/1/2008 | E-120-2003/2 | 7,378,276 | Method of Inducing Memory B Cell Development and Terminal Differentiation |
| 5/1/2008 | E-286-2006/2 | | A Novel Growth Factor and Anti-Apoptotic Agent for Promoting Lung Development and Treating Lung Disease |
| 5/1/2008 | E-129-2008/0 | | Synthetic Analogs of Juxtamembrane Domain of IGF-1 Receptor as Anti-Cancer Agents |
| 5/1/2008 | E-110-2006/0 | | Muramyl Dipeptide as a Therapeutic Agent for Inflammation |
| 5/1/2008 | E-206-1995/3 | 6,320,022
7,101,548 | Treatment and Diagnosis of Cancer, Diabetes and other Disorders Using Adrenomedullin Peptides and Antibodies |
| 3/1/2008 | E-154-2007/0 | | VEGF-B as a Therapeutic Agent for Neurodegenerative Disease |
| 3/1/2008 | E-217-2007/0 | | N-Acetyl Mannosamine as a Therapeutic Agent |
| 2/1/2008 | E-172-2007/2 | | Collagen-Induced Platelet Aggregation Inhibitor from Mosquito Salivary Glands |
| 2/1/2008 | E-203-2000/0 | 7,144,918 | Biologically Active Macrolides, Compositions and Uses Thereof |
| 2/1/2008 | E-069-2000/2
E-069-2000/3 | 7,196,074 | Preparation and Use of Androgenic Compounds |
| 1/1/2008 | E-108-2007/0 | | Photosensitization by Nuclear Receptor-Ligand Complexes and Cell Ablation Uses Thereof |
| 12/1/2007 | E-168-2007/0 | | Treatment for Chronic Inflammatory Disease and Cancer by Inhibition of MMP-1 |
| 10/1/2007 | E-064-2005/0 | | Biomarkers for Tissue Status |
| 9/1/2007 | E-174-2007/0 | | Suppression of Allergic Asthma by Ascaris Antigens |
| 8/1/2007 | E-138-1992/1 | 5,877,179 | Treatment for Cystic Fibrosis Cells and Other Reduced Cl- Conductance Cells |
| 8/1/2007 | E-068-1998/0 | 6,685,933
7,235,232 | Interferon Alpha Hybrids |
| 8/1/2007 | E-282-2002/0 | | Methods and Compositions for Treating Diseases and Disorders Associated with Natural Killer T-Cells |
| 7/1/2007 | E-089-2005/0 | | Benztropinamine Analogs as Dopamine Transport Inhibitors |
| 7/1/2007 | E-149-2005/0 | | Methods and Materials for Identifying Polymorphic Variants, Diagnosing Susceptibilities, and Treating Disease |
| 7/1/2007 | E-059-2006/0 | | Method of Treating or Preventing Oxidative Stress-related Diseases (stroke and neurodegenerative diseases, wound healing and cardiovascular diseases) |
| 6/1/2007 | E-012-1991/0
E-012-1991/2
E-044-1997/0
E-044-1997/1 | 5,167,956
5,725,857
6,632,928 | Immunotoxin with in-vivo T cell Suppressant Activity |
| 6/1/2007 | E-088-2007/0 | | Zscan4: A Gene Critical for Early Embryonic Development |
| 6/1/2007 | E-012-1991/0
E-012-1991/4
E-012-1991/7
E-044-1997/0
E-044-1997/1
E-059-1998/0
E-168-1999/0 | 5,167,956
5,762,927
6,103,235
6,632,928
7,288,254 | Methods of Inducing Immune Tolerance Using Immunotoxins |
| 6/1/2007 | E-137-1993/0 | 5,554,603 | Orally Active Derivatives of 1,3,5(10)-estratriene |
| 5/1/2007 | E-056-2004/0 | | STAMP, A Novel Cofactor and Possible Steroid Sparing Agent, Modulates Steroid-induced Induction or Repression of Steroid Receptors |
| 5/1/2007 | E-140-2006/0 | | A Fullerene-based Anticoagulant |
| 5/1/2007 | E-168-2001/0
E-168-2001/1 | 7,192,705 | TMC1, a Deafness-Related Gene |
| 5/1/2007 | E-281-2002/0 | 7,193,053 | Leu574 of HIF-1alpha as a Molecular Basis for Therapeutic Application |
| 4/1/2007 | E-181-2004/0 | | Preparation and Use of Androgenic Compounds: Nandrolone 17beta-carbonates |
| 4/1/2007 | E-205-2006/2 | | Preparation of (R,R)-Fenoterol and (R,R)-or (R,S)-Fenoterol Analogues and Their Use in Treating Congestive Heart Failure |
| 4/1/2007 | E-011-2007/0 | | Methods for Treating Autoimmune Inflammatory Disease by Blocking DR3-TL1A Interactions |
| 4/1/2007 | E-103-2000/0
E-103-2000/1
E-103-2000/2
E-305-2005/0 | 6,753,317
6,916,905 | Novel Dmt-Tic Analogues Specific for Delta- and Mu-Opioid Receptors |
| 4/1/2007 | E-014-2002/0 | | Neural Crest-Melanocyte cDNA Based Microarray Analysis for Human Skin Pigmentation Research |
| 1/1/2007 | E-234-2005/1 | | Novel Benztropine Analogs for Treatment of Cocaine Abuse and Other Mental Disorders |
| 1/1/2007 | E-201-1989/0 | 5,420,033 | Epithelial Cell Line Expressing a Cystic Fibrosis Phenotype |
| 12/1/2006 | E-347-2004/0 | | ARH3, a Therapeutic Target for Cancer, Ischemia, and Inflammation |
| 12/1/2006 | E-014-2007/0 | | Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents |
| 11/1/2006 | E-186-2006/0 | | Second Generation Nitric Oxide-releasing Non-steroidal Anti-inflammatory Drugs Possessing a Diazeniumdiolate Group (NONO-NSAIDs) |
| 9/1/2006 | E-007-1996/0 | 6,635,614
728257 | Use of LCAT to Reduce Cholesterol and Prevent Atherosclerosis |
| 9/1/2006 | E-262-2003/0 | | Methods for Enhancing Beta Cell Function in Diabetes |
| 8/1/2006 | E-042-2006/0 | | Complement Regulatory Gene Variants as Predictive Tests for Age-related Macular Degeneration (AMD) |
| 8/1/2006 | E-336-2001/0 | | Amyloid Beta is a Ligand for FPR Class Receptors |
| 7/1/2006 | E-017-2004/0 | | Methods and Compositions Related to GHS-R Antagonist |
| 6/1/2006 | E-108-2005/0 | | Treatment of Inflammatory Bowel Disease (IBD) using NF-KB Decoy Polynucleotides |
| 6/1/2006 | E-003-2005/0 | | Treatment and Prevention of Inflammatory Bowel Disease (IBD) using Mutant and Chimeric IL-13 Molecules |
| 5/1/2006 | E-055-1999/0 | 6,680,176 | Identification of Candidate Ligands which Modulate Antigen Presenting Cells |
| 5/1/2006 | E-075-2003/0 | | Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof |
| 3/1/2006 | E-263-2003/0 | | Immunogenic T Cell Targets in Autoimmune Hepatitis and Methods of Use |
| 3/1/2006 | E-262-1999/1 | 7,459,536 | Monoclonal Antibodies Which Specifically Bind to the Ligand Hepatocyte Growth Factor (HGF) and are Useful in the Treatment of Cancer |
| 3/1/2006 | E-208-2003/0 | | TNF-alpha Converting Enzyme Inhibitory Agents and Stimulatory Agents |
| 9/1/2005 | E-009-1991/0
E-009-1991/1
E-301-1998/2 | 5,217,953
5,565,424 | Cancer Therapy Using Vasoactive Intestinal Peptide Antagonists |
| 9/1/2005 | E-105-2002/0 | | Regulation of INS (3456) P4 Signaling by a Reversible Kinase/Phosphatase and Methods and Compositions Related Thereto |
| 8/1/2005 | E-092-2004/0 | | Anti-Marinobufagenin Antibodies and Methods for Their Use |
| 7/1/2005 | E-033-2004/0 | | Multipotent Postnatal Stem Cells From Human Periodontal Ligament and Uses Thereof |
| 6/1/2005 | E-188-2004/0 | | Therapeutic Delivery of Nitric Oxide From Novel Diazeniumdiolated Derivatives of Acrylonitrile-based Polymers |
| 5/1/2005 | E-199-1999/0 | | Mycolactone and Related Compounds |
| 4/1/2005 | E-318-2004/0 | | Regulation of ATG7 Beclin 1 Program of Autophagic Cell Death by Caspase-8 |
| 4/1/2005 | E-070-1982/2 | 5,656,587
5,705,477 | Compositions of Transforming Growth Factor Beta (TGF-beta) Which Promotes Wound Healing and Methods for Their Use |
| 4/1/2005 | E-252-1999/0 | 6,916,843 | Endothelial Protective Actions of Cytochrome P450 Epoxygenase-derived Eicosanoids |
| 3/1/2005 | E-010-2004/2 | | Modulating P38 Kinase Activity |
| 2/1/2005 | E-328-2004/0 | | Methods for Treating Active Uveitis |
| 2/1/2005 | E-248-2004/0 | | A3 Adenosine Receptor Agonists |
| 2/1/2005 | E-355-2004/0 | | Compositions and Methods for the Treatment of Immune-Related Disease |
| 2/1/2005 | E-094-2003/0 | | A Novel, Preservative-Free Steroid Formulation for Use as an Anti-Inflammatory |
| 1/1/2005 | E-130-2004/0 | | Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson’s and Alzheimer’s Disease |
| 1/1/2005 | E-244-2004/0 | | The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof |
| 1/1/2005 | E-259-2003/0 | | Anti-Proliferative Activity of an Unexpected mTOR Kinase Inhibitor |
| 1/1/2005 | E-131-2002/0 | | A Method of Treating Inflammatory Bowel Disease (IBD) |
| 1/1/2005 | E-102-2004/0 | | Treatment of Inappropriate Immune Responses |
| 1/1/2005 | E-208-2002/0 | | Applications for the HMGN1 Pathway |
| 12/1/2004 | E-332-2004/0 | | The Use of Rabbits with Defined Immunoglobulin Light Chain Genes (Ckappa b allotypes) to Optimize Production of Chimeric and Humanized Monoclonal Antibodies for Therapeutic, Imaging and Diagnostic Applications |
| 12/1/2004 | E-072-2000/0 | 6,855,314 | AAV5 Vector for Transducing Brain Cells and Lung Cells |
| 12/1/2004 | E-204-1999/0 | 7,238,473 | TTP as a Regulator of GM-CSF mRNA Deadenylation and Stability |
| 8/1/2004 | E-211-2003/0 | | A Combined Immunosuppressive Therapy Consisting of Glucocorticoid and rIL-2 |
| 6/1/2004 | E-016-2004/0 | | Methods for Inhibiting Proinflammatory Cytokine Expression Using Ghrelin |
| 5/1/2004 | E-211-2002/0
E-211-2002/1 | 7,332,645 | IL-21 Critically Regulates Immunoglobulin Production |
| 4/1/2004 | E-048-2004/2 | | Construction of a Recombinant Mammalian Expression System for the Production of Human TGF-beta 1 and Members of TGF-beta Superfamily Cytokines |
| 2/1/2004 | E-151-1992/0 | 5,935,575 | Interleukin-4 Stimulated T-Lymphocyte Cell Death for the Treatment of Autoimmune Diseases, Allergic Disorders and Graft Rejection |
| 2/1/2004 | E-137-1991/0 | 5,989,546
6,083,503 | Interleukin-2 Stimulated T-Lymphocyte Cell Death for the Treatment of Autoimmune Diseases, Allergic Disorders and Graft Rejection |
| 2/1/2004 | E-286-2002/0
E-286-2002/1
E-286-2002/2 | | Aerosolized Capreomycin for Inhibition of Pulmonary Tuberculosis |
| 12/1/2003 | E-081-2002/0 | | A Mouse Model for Human Osteoarthritis |
| 11/1/2003 | E-223-2002/0 | | Factors That Bind Intestinal Toxins |
| 10/1/2003 | E-001-2003/0
E-001-2003/1
E-019-2003/0 | | Methods and Materials for Controlling Stem Cell and Cancer Cell Proliferation and Differentiation |
| 10/1/2003 | E-294-2002/0 | 7,462,593 | A New Target for Angiogenesis and Anti-Angiogenesis Therapy |
| 8/1/2003 | E-329-2001/0 | 7,220,582 | Stem Cells that Transform to Beating Cardiomyocytes |
| 8/1/2003 | E-301-2002/0 | | Cycloxygenase Inhibition with Nitroxyl |
| 8/1/2003 | E-273-2002/0 | 6,936,639 | Nitroxyl Progenitors in the Treatment of Heart Failure |
| 8/1/2003 | E-293-2002/0 | 7,364,719 | Vasopressor Peptide Derived From Adrenomedullin and Methods of Its Use |
| 8/1/2003 | E-143-2002/0
E-143-2002/1 | 7,258,859
7,575,742 | Method for the Treatment of Multiple Sclerosis |
| 7/1/2003 | E-281-2001/0 | 7,220,718 | Oral Treatment of Hemophilia |
| 6/1/2003 | E-113-2002/0 | | Method for Preparing 17alpha-acetoxy-11beta-(4,N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, Intermediates Thereof, and Methods for the Preparation of Such Intermediates |
| 5/1/2003 | E-097-2003/0 | | Triggering Receptors Expressed in Myeloid Cells (TREM) Like Transcript (TLT-1), A Novel Inhibitory Receptor of Platelets and Uses Therefore |
| 5/1/2003 | E-076-2003/0
E-175-2002/0 | | Method of Treating Ischemia/Reperfusion Injury with Nitroxyl Anion Donors |
| 5/1/2003 | E-149-2001/0
E-276-2002/0 | 6,673,338
6,949,530
7,105,502
7,348,319 | Preparation and Medical Uses of Novel Nitric Oxide Releasing Imidates, Amidines Derived Therefrom, and Enamines |
| 5/1/2003 | E-176-1999/0 | 7,087,589 | Methanocarba Cycloalkyl Nucleoside Analogues |
| 4/1/2003 | E-060-2000/0
E-060-2000/1 | 4248600
7,488,710 | sFRP and Peptide Motifs That Interact with sFRP and Methods of Their Use |
| 3/1/2003 | E-261-2000/0 | 7,375,185 | Optimization of Cardiac Contraction by Novel Human Kinase Mediated Differential Phosphorylation of Myosin |
| 3/1/2003 | E-189-2002/0 | 7,468,435 | Novel Cyclic Polyamines That Release Nitric Oxide in a Biphasic Manner |
| 3/1/2003 | E-185-1997/2 | 6,368,828 | Attenuated and Dominant Negative Variant cDNAs of STAT6: STAT6b and STAT6c |
| 11/1/2002 | E-080-2002/0 | 7,511,015 | Modified Defensins and Their Use |
| 11/1/2002 | E-296-2001/0 | 7,541,040 | Alleviating Symptoms of Th2-Like Cytokine Mediated Disorders by Reducing IL-13 Receptor-Expressing Cells in the Respiratory Tract |
| 8/1/2002 | E-053-2002/0 | 7,563,766 | Methods and Compositions for the Promotion of Hair Growth Utilizing Actin-Binding Peptides |
| 5/1/2002 | E-113-1999/0 | | Sol Fusin: Use of GP64-6HIS to Catalyze Membrane Fusion |
| 3/1/2002 | E-360-2001/0 | | Generation and Use of Tc1 and Tc2 Cells |
| 9/1/2001 | E-067-2001/0 | | Secretion of Native Recombinant Lysosomal Enzymes by Liver |
| 4/1/2001 | E-237-1999/0 | 7,261,896 | Methods for Preventing Strokes by Inducing Tolerance to E-selectin |
| 2/1/2001 | E-015-2000/0 | | Antiprogestins with Partial Agonist Activity |
| 12/1/2000 | E-123-1999/0 | 7,122,624 | PTH2 and PTH1 Receptor Ligands |
| 9/1/2000 | E-061-1999/0 | | Polypeptides Comprising IL-6 Ligand Binding Receptor Domains and Related Nucleic Acids, Antibodies, Compositions and Methods |
| 8/1/2000 | E-041-2000/0 | 6,448,245 | HIV Protease Inhibitors, Ritonavir and Saquinavir are Potent Inhibitors of Calcium Activated Neutral Peptidases, Calpains |
| 8/1/2000 | E-149-1999/0 | 6,852,686 | Ichthyosiform Skin Diseases |
| 4/1/2000 | E-257-1999/0 | | Methods and Compositions for Correlating CCR5 Expression with Essential Hypertension |
| 8/1/1999 | E-045-1994/0
E-045-1994/1 | 5,587,309
5,888,705 | Methods of Stimulating Proliferation and Differentiation of Human Pancreatic Cells Ex Vivo |
| 8/1/1999 | E-169-1999/0 | 7,129,052 | Peptides and Their Utility in Modulation of Behavior of Cells Expressing alpha3beta1 Integrins |
| 7/1/1999 | E-127-1996/0 | 5,998,598 | Immunoadhesins and Methods of Production Thereof |
| 7/1/1999 | E-200-1997/0 | 6,479,465 | Methods of Treating Colitis Using STAT-4 Antisense Oligonucleotide |
| 6/1/1999 | E-093-1996/0
E-093-1996/1
E-093-1996/2
E-093-1996/3 | 6,610,660
6,911,433
7,081,524 | O2-Arylated or O2-Glycosylated 1-Substituted Diazen-1-ium-1,2-diolates and O2-Substituted 1-[(2-Carboxylato)Pyrolidin-1-yl] Diazen-1-ium-1,2-diolates |
| 6/1/1999 | E-282-1998/0 | | Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases |
| 2/1/1999 | E-163-1996/0 | 6,458,590 | Methods and Compositions for Treatment of Restenosis |
| 12/1/1998 | E-137-1996/0 | 6,326,466 | Double-Stranded RNA Dependent Protein Kinase Derived Peptides To Promote Proliferation Of Cells And Tissues In A Controlled Manner |
| 11/1/1998 | E-182-1997/0 | 6,562,859 | Ureido Derivatives Of Poly-4-Amino-2-Carboxy-1-Methyl Pyrrole Compounds For Treatment Of Inflammation |
| 10/1/1998 | E-009-1996/0 | 6,365,712
6,846,911 | Methods And Compositions For Inhibiting Inflammation And Angiogenesis |
| 9/1/1998 | E-153-1997/0 | 6,084,063 | Signal Transduction Inhibitors Of Allergic Reactions |
| 9/1/1998 | E-166-1998/0 | 7,504,096 | LIF And Related Cytokines That Operate Through The gp130 Receptor Pathway As A Means To Enhancing Embryo Implantation In Mammals And As An Alternative To Using Estrogen |
| 1/1/1998 | E-159-1996/0 | | Formation Of Human Bone In Vivo |
| 11/1/1997 | E-257-1997/0 | 6,627,745 | Identification Of The Gene Causing Familial Mediterranean Fever |
| 5/1/1997 | E-090-1991/0 | 5,328,990
5,656,737 | Macrophage Migration Inhibitory Factor (MIF) |
| 4/1/1997 | E-139-1994/0 | 5,637,323 | Method Of Mobilizing Pluripotent Hematopoietic Stem Cells And Accelerating Leukocyte Reconstitution With IL-7 |
| 1/1/1997 | E-132-1996/0 | 6,780,413 | Immunotoxin (MAB-RICIN) For The Treatment Of Focal Movement Disorders |
| 12/1/1996 | E-184-1995/0
E-184-1995/1 | | Materials And Methods For Detection And Treatment Of Insulin Dependent Diabetes |
| 7/1/1996 | E-083-1990/0 | 5,219,991
5,527,685 | Macrophage Stimulating Protein |
| 7/1/1996 | E-097-1995/0 | 5,853,697 | Methods Of Treating Established Colitis Using Antibodies Against IL-12 |
| 7/1/1996 | E-002-1986/0 | 5,352,772 | 75 Kilodalton Interleukin-2 Receptor Proteins And Their Use |
| 4/1/1996 | E-001-1989/0 | 5,532,144
6,090,795 | Human Derived Monocyte Attracting Purified Peptide Products For Treating Human Infection And Neoplasms |
| 4/1/1996 | E-176-1995/0 | 6,265,160 | Method Of Identifying Inhibitors Of The Jak-STAT Signal Transduction Pathway |
| 2/1/1996 | E-068-1993/0 | 5,556,754
5,871,950 | Methods For Treating Autoimmune Diseases And Transplantation Rejection |
| 2/1/1996 | E-263-1988/0 | 5,585,346 | Peptide Derivatives Of Cytochrome b558 And Their Use As Medicaments [As Anti-Inflammatory Agents] |
| 11/1/1993 | E-079-1993/0
E-079-1993/1 | 5,518,880
5,912,173 | Methods for Diagnoses and Treatment of XSCID |